Monitoring of benzodiazepine diversion using a multi-indicator approachPAULY, Vanessa; FRAUGER, Elisabeth; PRADEL, Vincent et al.International clinical psychopharmacology. 2011, Vol 26, Num 5, pp 268-277, issn 0268-1315, 10 p.Article

Application of a Policy Framework for the Public Funding of Drugs for Rare DiseasesWINQUIST, Eric; COYLE, Doug; CLARKE, Joe T. R et al.Journal of general internal medicine. 2014, Vol 29, issn 0884-8734, S774-S779, SUP3Article

Toward a Functional Definition of a Rare Disease for Regulatory Authorities and Funding AgenciesCLARKE, Joe T. R; COYLE, Doug; EVANS, Gerald et al.Value in health. 2014, Vol 17, Num 8, pp 757-761, issn 1098-3015, 5 p.Article

Dosage of angiotensin-II receptor blockers in heart failure patients following changes in Danish drug reimbursement policiesSELMER, Christian; LAMBERTS, Morten; KRISTENSEN, Søren Lund et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 12, pp 1281-1287, issn 1053-8569, 7 p.Article

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series studyHSU, Jason C; LU, Christine Y; WAGNER, Anita K et al.Health policy (Amsterdam. Print). 2014, Vol 116, Num 2-3, pp 196-205, issn 0168-8510, 10 p.Article

Impact analysis of the discontinuation of reimbursement : the case of oral contraceptivesSTOLK, Pieter; SCHNEEWEISS, Sebastian; LEUFKENS, Hubert G. M et al.Contraception (Stoneham). 2008, Vol 78, Num 5, pp 399-404, issn 0010-7824, 6 p.Article

Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation: an Italian perspectiveALLEGRA, C.Current medical research and opinion. 2003, Vol 19, Num 8, pp 761-769, issn 0300-7995, 9 p.Article

Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over timeSANDMANN, Frank G; FRANKEN, Margreet G; STEENHOEK, Adri et al.Health policy (Amsterdam. Print). 2013, Vol 112, Num 3, pp 285-296, issn 0168-8510, 12 p.Article

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abusePAULY, Vanessa; FRAUGER, Elisabeth; PRADEL, Vincent et al.Drug and alcohol dependence. 2011, Vol 113, Num 1, pp 29-36, issn 0376-8716, 8 p.Article

An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: The trastuzumab caseADES, Felipe; SENTERRE, Chistelle; ZARDAVAS, Dimitrios et al.European journal of cancer (1990). 2014, Vol 50, Num 18, pp 3089-3097, issn 0959-8049, 9 p.Article